Literature DB >> 27161868

The Properties of 3 Different Plasma Formulations and Their Effects on Tendinopathic Cells.

Eva Rubio-Azpeitia1, Ane M Bilbao2, Pello Sánchez2, Diego Delgado2, Isabel Andia3.   

Abstract

BACKGROUND: Tendinopathies are attributed to failure of the healing process and inadequate tissue remodeling. Plasma injections can trigger regenerative responses by modifying the molecular microenvironment.
PURPOSE: To examine the differences in the mitotic, chemotactic, anabolic, and inflammatory effects between leukocyte- and platelet-rich plasma (L-PRP), platelet-rich plasma (PRP), and platelet-poor plasma (PPP). STUDY
DESIGN: Controlled laboratory study.
METHODS: Tendinopathic cells were cultured in 3-dimensional (3D) hydrogels formed using PPP, PRP, and L-PRP. Cell migration was evaluated using a μ-Slide chemotaxis chamber with video microscopy. Proliferation was assessed using XTT assays. Expression of genes associated with matrix turnover, including type 1 collagen (COL1A1), COL3A1, aggrecan, decorin, fibronectin, matrix metalloproteinase 1 (MMP-1), MMP-3, A Disintegrin-Like And Metalloprotease With Thrombospondin Type 1 Motif proteins 4 (ADAMTS-4), and ADAMTS-5, was assessed using real-time reverse-transcription polymerase chain reaction. Secreted inflammatory proteins, including interleukin (IL)-1β, IL-6, IL-8, monocyte chemotactic protein 1 (MCP-1), and regulated on activation, normal T cell expressed and secreted (RANTES), as well as vascular endothelial growth factor (VEGF) and connective tissue growth factor (CTGF), were quantified using enzyme-linked immunosorbent assay.
RESULTS: Tendinopathic cells migrate at a higher velocity along L-PRP and PRP than along PPP gradients. PRP and L-PRP promote hypercellularity. PPP and PRP showed more pronounced anabolic properties, as demonstrated by enhanced COL1A1 and COL3A1 and reduced MMP-1 expression. Decorin, fibronectin, and aggrecan were downregulated in L-PRP compared with PPP and PRP. L-PRP and PRP were shown to be more proinflammatory than PPP in terms of IL-6 secretion, but cells in PPP showed MCP-1(high) phenotype. CTGF secretion was significantly reduced in L-PRP compared with PPP and PRP.
CONCLUSION: The main advantages of L-PRP and PRP use, compared with PPP, include their stronger chemotactic and proliferative properties. While PPP and PRP stimulate matrix anabolism, L-PRP is more proinflammatory. Emphasis should be placed on the temporal needs and biological characteristics of injured tendons, and plasma formulations need to be tailored accordingly. CLINICAL RELEVANCE: Versatile systems allowing the preparation of different plasma formulations, such as PPP, PRP, or L-PRP, can help refine clinical applications by taking advantage of their different biological properties.
© 2016 The Author(s).

Entities:  

Keywords:  PPP; PRP; anabolism; chemotaxis; inflammation; leukocyte-rich PRP; tendinopathy; tissue healing

Mesh:

Substances:

Year:  2016        PMID: 27161868     DOI: 10.1177/0363546516643814

Source DB:  PubMed          Journal:  Am J Sports Med        ISSN: 0363-5465            Impact factor:   6.202


  11 in total

1.  Platelet-rich plasma or blood-derived products to improve endometrial receptivity?

Authors:  Adriana Bos-Mikich; Marcelo O Ferreira; Ricardo de Oliveira; Nilo Frantz
Journal:  J Assist Reprod Genet       Date:  2019-01-04       Impact factor: 3.412

Review 2.  Biological Therapies in Regenerative Sports Medicine.

Authors:  Isabel Andia; Nicola Maffulli
Journal:  Sports Med       Date:  2017-05       Impact factor: 11.136

Review 3.  Platelet-rich plasma: combinational treatment modalities for musculoskeletal conditions.

Authors:  Isabel Andia; Michele Abate
Journal:  Front Med       Date:  2017-10-18       Impact factor: 4.592

4.  Impact of Platelet-Rich Plasma Use on Pain in Orthopaedic Surgery: A Systematic Review and Meta-analysis.

Authors:  Herman Johal; Moin Khan; Shu-Hang Patrick Yung; Mandeep S Dhillon; Freddie H Fu; Asheesh Bedi; Mohit Bhandari
Journal:  Sports Health       Date:  2019-05-28       Impact factor: 3.843

5.  Adult Cells Combined With Platelet-Rich Plasma for Tendon Healing: Cell Source Options.

Authors:  Eva Rubio-Azpeitia; Pello Sánchez; Diego Delgado; Isabel Andia
Journal:  Orthop J Sports Med       Date:  2017-02-24

Review 6.  Platelet-Rich Plasma Versus Corticosteroids for Plantar Fasciitis: A Systematic Review of Randomized Controlled Trials.

Authors:  Eoghan T Hurley; Yoshiharu Shimozono; Charles P Hannon; Niall A Smyth; Christopher D Murawski; John G Kennedy
Journal:  Orthop J Sports Med       Date:  2020-04-27

7.  Liquid Platelet-Rich Fibrin and Heat-Coagulated Albumin Gel: Bioassays for TGF-β Activity.

Authors:  Zahra Kargarpour; Jila Nasirzade; Layla Panahipour; Richard J Miron; Reinhard Gruber
Journal:  Materials (Basel)       Date:  2020-08-06       Impact factor: 3.748

8.  In vitro effect of triamcinolone and platelet-rich plasma on cytokine levels of elbow lateral epicondylitis-derived cells.

Authors:  Márcio Eduardo de Melo Viveiros; Magda Massae Hata Viveiros; Márcia Guimarães da Silva; Cláudia Aparecida Rainho; Silvana Artioli Schellini
Journal:  J Orthop Surg Res       Date:  2022-02-15       Impact factor: 2.359

Review 9.  Current trends in tendinopathy: consensus of the ESSKA basic science committee. Part II: treatment options.

Authors:  F Abat; H Alfredson; M Cucchiarini; H Madry; A Marmotti; C Mouton; J M Oliveira; H Pereira; G M Peretti; C Spang; J Stephen; C J A van Bergen; L de Girolamo
Journal:  J Exp Orthop       Date:  2018-09-24

Review 10.  Role of Mechanical Loading for Platelet-Rich Plasma-Treated Achilles Tendinopathy.

Authors:  Alyssa Neph; Allison Schroeder; Keelen R Enseki; Peter A Everts; James H-C Wang; Kentaro Onishi
Journal:  Curr Sports Med Rep       Date:  2020-06       Impact factor: 1.733

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.